Home > Publications database > Molecular imaging in early diagnosis, differential diagnosis and follow-up of patients with neurodegenerative diseases > print

001     844289
005     20210129232850.0
024 7 _ |2 doi
|a 10.1007/s40336-017-0242-y
024 7 _ |2 ISSN
|a 2281-5872
024 7 _ |2 ISSN
|a 2281-7565
024 7 _ |2 WOS
|a WOS:000411570700006
024 7 _ |a altmetric:24461802
|2 altmetric
037 _ _ |a FZJ-2018-01729
082 _ _ |a 610
100 1 _ |0 0000-0003-2850-9450
|a Hammes, Jochen
|b 0
|e Corresponding author
245 _ _ |a Molecular imaging in early diagnosis, differential diagnosis and follow-up of patients with neurodegenerative diseases
260 _ _ |a Berlin
|b Springer Milan
|c 2017
336 7 _ |2 DRIVER
|a article
336 7 _ |2 DataCite
|a Output Types/Journal article
336 7 _ |0 PUB:(DE-HGF)16
|2 PUB:(DE-HGF)
|a Journal Article
|b journal
|m journal
|s 1520521453_23726
336 7 _ |2 BibTeX
|a ARTICLE
336 7 _ |2 ORCID
|a JOURNAL_ARTICLE
336 7 _ |0 0
|2 EndNote
|a Journal Article
520 _ _ |a PurposeCurrent disease models suggest that many neurodegenerative disorders are associated with pathological protein aggregations that start to develop in the brain long before the onset of clinical symptoms. Therefore, biomarkers allowing early and reliable characterization of neurodegenerative disease are required. Here we illustrate the potential value of neuroimaging procedures by means of selected examples.MethodsMultimodal imaging data of exemplary patients who underwent FDG, Amyloid and AV-1451-PET, FP-CIT-SPECT and MRI imaging in the routine clinical workup in our department is presented and the currently available literature on the topic of imaging in neurodegenerative diseases was reviewed.ResultsThe complementary value of the applied imaging methods is demonstrated in pairs of representative cases. Depending on the clinical question, individual methods or a meaningful multimodal combination is required to achieve optimal diagnostic benefit.
536 _ _ |0 G:(DE-HGF)POF3-572
|a 572 - (Dys-)function and Plasticity (POF3-572)
|c POF3-572
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef
700 1 _ |0 P:(DE-Juel1)166265
|a Bischof, Gérard N.
|b 1
700 1 _ |0 P:(DE-HGF)0
|a Drzezga, Alexander
|b 2
773 _ _ |0 PERI:(DE-600)2712000-4
|a 10.1007/s40336-017-0242-y
|g Vol. 5, no. 5, p. 465 - 471
|n 5
|p 465 - 471
|t Clinical and translational imaging
|v 5
|x 2281-7565
|y 2017
856 4 _ |u https://juser.fz-juelich.de/record/844289/files/10.1007_s40336-017-0242-y.pdf
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/844289/files/10.1007_s40336-017-0242-y.gif?subformat=icon
|x icon
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/844289/files/10.1007_s40336-017-0242-y.jpg?subformat=icon-1440
|x icon-1440
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/844289/files/10.1007_s40336-017-0242-y.jpg?subformat=icon-180
|x icon-180
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/844289/files/10.1007_s40336-017-0242-y.jpg?subformat=icon-640
|x icon-640
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/844289/files/10.1007_s40336-017-0242-y.pdf?subformat=pdfa
|x pdfa
|y Restricted
909 C O |o oai:juser.fz-juelich.de:844289
|p VDB
910 1 _ |0 I:(DE-588b)5008462-8
|6 P:(DE-Juel1)166265
|a Forschungszentrum Jülich
|b 1
|k FZJ
913 1 _ |0 G:(DE-HGF)POF3-572
|1 G:(DE-HGF)POF3-570
|2 G:(DE-HGF)POF3-500
|a DE-HGF
|b Key Technologies
|l Decoding the Human Brain
|v (Dys-)function and Plasticity
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
914 1 _ |y 2018
915 _ _ |0 StatID:(DE-HGF)0200
|2 StatID
|a DBCoverage
|b SCOPUS
915 _ _ |0 StatID:(DE-HGF)0300
|2 StatID
|a DBCoverage
|b Medline
915 _ _ |0 StatID:(DE-HGF)0199
|2 StatID
|a Clarivate Analytics Master Journal List
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)INM-3-20090406
|k INM-3
|l Kognitive Neurowissenschaften
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-Juel1)INM-3-20090406
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21